Dyne Therapeutics, Inc. (DYN) has a consensus analyst rating of Buy, based on 13 analysts covering the stock. Of those, 12 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for DYN is $37.60, representing a +89.8% upside from the current price of $19.81. Price targets range from a low of $23.00 to a high of $60.00.
